Scientific information - Clinical trials
The genes of SemperSan® management is characterized by search & discovery of unique food/consumer product innovations which are then tested & confirmed by working with international leading scientific experts/research institutiones in all phases of product development thus ensuring top quality.
R&D base
- Successful scientific basic in vivo studies (sugar rats) at the leading German
Institute of Diabetes “G.Katsch” , Karlsburg + Additional involvement of top-level scientific research Institutes like: - Technical University Munich
TopLab Institute, Munich
Cell Culture Service, Hamburg - Institute of Food Technology, University of Life Science, Vienna
- Institute of Taste Research, University Vienna
- Institute of nutritional science, University Vienna
- Bio-technology consulting, Vienna
- Institute of Diabetes/Nutrition,University of Alberta/CA
- Food Technology Consulting, Salzburg
- Hoffmann.Eitle patent attorneys, Munich, Germany
- INITS, Vienna`s High-Tech Incubator
- Institute of Diabetes, Medical University Graz, Austria
Pancreas untreated
The revolutionary discovery:
A food substance regulates the
insulin secretion in the pancreas
Pancreas SemperSan® treated
SemperSan® treated
Hypertrophy and destruction of
the islet cells were reduced
Clinical Studies
- Successful scientific basic in vivo animal studies at the leading
German Institute of Diabetes “G.Katsch” (Zucker rats), Karlsburg/Germany - Human study protocol designed –in cooperation with University of Alberta/Canada in coordination with experts:
- Prof. B. Fischer and Prof. H. Jäger, University Vienna.
- Additional involvement of University of California
Prof. E. Meyer, David Giffen School of Medicine at UCLA
Austrian Institute of Technology - Dr M. Boland principal scientist Massey University/NZ